What it sells
AI Agents for Oncology EHRs
Business model breakdown
Buyer: who owns the budget?
UnverifiedOncology/cancer center leaders and life-sciences trial teams.
Trigger: what makes them buy now?
Clinical teams spend hours reading hundreds of pages of oncology notes for trial matching, visit prep and registry curation.
Workflow: what inputs become what output?
Reads full longitudinal EHR record and produces structured cited outputs: PRISM trial matching, Symphony visit prep, Harmony cancer registry/QI data curation.
Economics: what it saves and how it charges
UnverifiedEnterprise contracts with cancer centers and life-sciences sponsors; raised $22M.
Distribution: how it reaches customers
Demo-led ("Book a demo"); customers include Mount Sinai.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.